Final STRATO Clinical Study Data Demonstrates Potential For LCP-Tacro™ To ... Daily Markets (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ – Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney ... |
